 Home > Medical News > Latest Medical News > Langlai Technology's IRAK4 inhibitor MY004 clinical trial application was accepted by NMPA

Langlai Technology's IRAK4 inhibitor MY004 clinical trial application was accepted by NMPA

 Last Update: 2021-04-24
 Source: Internet
 Author: User

Tags

monoclonal antibody development

2 4 products

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Recently, the Center for Drug Evaluation (CDE) of the National Medical Products Administration disclosed the inhibition of Interleukin-1 receptor-associated kinase 4 (IRAK4) by Meiyue Bio-Interleukin-1 receptor-associated kinase 4 (IRAK4), a Shanghai subsidiary of Wuhan Langlai Technology Development Co.

The purpose of the clinical study of MY004 application acceptance is to explore the safety, tolerability and pharmacokinetic properties of the drug in healthy subjects.

According to relevant information disclosure, the world's highest status of interleukin-1 receptor-related kinase 4 (IRAK4) inhibitors is currently phase II clinical, and the clinical POC for rheumatoid arthritis has been verified.

Note: The original text has been deleted

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.